Fresenius Kabi AG - Strategic SWOT Analysis Review

Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Fresenius Kabi AG (Fresenius Kabi), a subsidiary of Fresenius SE & Co. KGaA, develops, manufactures and markets pharmaceuticals and medical devices. The company's integrated product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and clinical nutrition products. It covers therapeutic areas such as blood volume substitution, fluid management, anesthesia, critical illness, cancer, liver insufficiency, renal insufficiency, maldigestion or malabsorption, diabetes mellitus and pediatrics. Its products and services are used for the treatment of critically and chronically ill patients. Fresenius Kabi conducts sales and marketing operations through direct offices worldwide. The company has manufacturing facilities in Europe, North America, Latin America, Asia Pacific and Africa. It has operational presence in North America, Latin America, Europe, the Middle East, Africa and Asia Pacific. Fresenius Kabi is headquartered in Bad Homburg, Germany.

Fresenius Kabi AG Key Recent Developments

Oct 21, 2015: Cerus Announces New Agreement With Fresenius Kabi for the Production of INTERCEPT Blood System Kits
Jan 26, 2015: Fresenius Kabi and Halyard Health enter Supply and Distribution Agreement for Halyard Health Elastomeric I .V. Infusion Pumps
Jan 12, 2015: Fresenius Kabi Receives FDA Status Upgrade For US Grand Island Facility

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Frequently Asked Questions